Article

A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral Discovery

2025-07-30

Abstract excerpt

The rapid emergence of viruses with pandemic potential continues to pose a threat to public health worldwide. With the typical drug discovery pipeline taking an average of 5–10 years to reach clinical readiness, there is an urgent need for strategies to develop broad-spectrum antivirals that can target multiple viral family members and variants of concern. We present a structure-based computational pipeline design...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6949e6b5-3d49-55dd-9337-e37aa76c4d1f
DOI: 10.1101/2025.07.29.667267

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral DiscoveryDOI 10.1101/2025.07.29.667267Read

High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent InhibitorSemantic proximity Read

The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugsSemantic proximity Read

A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screeningSemantic proximity Read

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read

A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual ScreeningSemantic proximity Read

Structure-based drug repurposing targeting pathogenic virus superfamily 1 helicase: An integrated multi-computational screening and bioactivity identification strategySemantic proximity Read

Genetic Variability of the SARS-CoV-2 PocketomeSemantic proximity Read

Integrated Docking and Enhanced Sampling Based Selection of Repurposing Drugs for SARS-CoV-2 by Targeting Host Dependent FactorsSemantic proximity Read

Identification of Potential Antiviral Lead Inhibitors Against Sars-Cov-2 Main Protease: Structure-Guided Virtual Screening, Docking, Adme, and Md Simulation Based ApproachSemantic proximity Read

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read

Compilation of Potential Protein Targets for SARS-CoV-2: Preparation of Homology Model and Active Site Determination for Future Rational Antiviral DesignSemantic proximity Read

Drug Design and Repurposing with DockThor-VS Web Server: Virtual Screening focusing on SARS-CoV-2 Therapeutic Targets and their Non-Synonym VariantsSemantic proximity Read